Fresenius Medical Care closes at $24.22 after gaining 2.71%

Friday at a glance: the US-German healthcare company went up to $24.22, gaining 2.71%.

Concerning technical analysis and more specifically, trend indicators, investors are seeking long positions as Fresenius Medical Care AG & Co. KGaA price action surged above +100 — a key CCI threshold indicating an imminent bullish trend. Momentum evaluation shows that the Relative Strength Index indicates Fresenius Medical Care is currently 'overbought' which suggests new gains will be harder to obtain. Asset volatility analysis shows that Fresenius Medical Care's upper Bollinger Band® is at $24.23, this is a slight indication of a slowdown. Fresenius Medical Care's notable support and resistance levels: Fresenius Medical Care could be slowing down soon; it is getting close to the resistance line and is now at $24.37, only 15 cents away. Crossing the resistance line could, however, suggest that further gains are ahead.

Notwithstanding Fresenius Medical Care's appreciation in recent days, the technical outlook suggests its bullish run is now fading.

A look at other health care stocks also showed bullish price action as Thermo Fisher Scientific traded at $554.9 after closing Friday's trading day at $543 (up 2.19%). AbbVie gained 1.51%, as it traded at $151.12.

Fresenius Medical Care went up Friday, yet these health care stocks did not follow — Sanofi went down 4.35%, closed at $56.09.

Furthermore, the market is looking at United States ISM Manufacturing PMI (Apr) is expected tomorrow at 14:00 UTC.

The US-German healthcare company has gained 52.42% since its lowest print of $12.81 earlier this year.